首页> 外文OA文献 >A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

【2h】

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

机译：具有复发/难治性神经母细胞瘤的儿童化疗和自然杀伤细胞的人源化抗GD2单克隆抗体（HU14.18K322A）的试验试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sara M. Federico; M. Beth McCarville; Barry L. Shulkin; Paul M. Sondel; Jacquelyn A. Hank; Paul Hutson; Michael Meagher; Aaron Shafer; Catherine Y. Ng; Wing Leung; William E. Janssen; Jianrong Wu; Shenghua Mao; Rachel C. Brennan; Victor M. Santana; Alberto S. Pappo; Wayne L. Furman;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma [J] . Federico Sara M., McCarville M. Beth, Shulkin Barry L., Clinical cancer research: an official journal of the American Association for Cancer Research . 2017 ,第21期

机译：具有复发/难治性神经母细胞瘤的儿童化疗和自然杀伤细胞的人源化抗GD2单克隆抗体（HU14.18K322A）的试验试验
2. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. [J] . Fariba Navid, Paul M Sondel, Raymond Barfield, Journal of Clinical Oncology . 2014 ,第14期

机译：新型抗GD2单克隆抗体Hu14.18K322A的I期试验，旨在降低对难治性或复发性神经母细胞瘤儿童的毒性。
3. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. [J] . Fariba Navid, Paul M Sondel, Raymond Barfield, Journal of Clinical Oncology . 2014 ,第14期

机译：新型抗GD2单克隆抗体Hu11.18K322A的I相试验，旨在减少耐火或复发性神经母细胞瘤的儿童的毒性。
4. Study of stability of expression of a humanized monoclonal antibody from a transfected NSO myeloma cell line using different culture media and serum concentrations [C] . CASTILLO A.J., VICTORES S., MARISON I.W Annual Meeting of the European Society of Animal Cell Technology . 1999

机译：使用不同培养基和血清浓度从转染的NSO骨髓瘤细胞中表达人源化单克隆抗体表达的稳定性研究
5. Transcriptional regulation of the production of a humanized monoclonal antibody by CHO cells [D] . Jiang, Zhou 2007

机译：CHO细胞产生人源化单克隆抗体的转录调控
6. Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody Hu14.18K322A Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma [O] . Fariba Navid, Paul M. Sondel, Raymond Barfield, -1

机译：一种新型抗GD2单克隆抗体Hu14.18K322A的I期试验旨在降低难治性或复发性神经母细胞瘤儿童的毒性
7. Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma [O] . Fariba Navid, Paul M. Sondel, Raymond Barfield, 2014

机译：I型新型抗GD2单克隆抗体Hu14.18K322A试验，旨在减少耐火或复发性神经母细胞瘤的儿童毒性
8. Humanized Monoclonal Antibody Specific to the Extracellular Domain of PSMA: Dose Escalation Trial in Patients with Prostate Cancer [R] . Vallabhajosula, S. 2003

机译：psma细胞外区特异性人源化单克隆抗体：前列腺癌患者的剂量递增试验

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

著录项

相似文献

相关主题

期刊订阅